Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

NEPTAZANE

METHAZOLAMIDE

Standard Dose
50MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview NEPTAZANE is listed in Drugs@FDA under application 011721 (NDA).

Marketing status: Discontinued Active ingredient METHAZOLAMIDE Form and strength TABLET;ORAL - 50MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor LEDERLE Submission history Latest submission status date: 2009-03-13 00:00:00.

Structured Monograph

Clinical summary

Approval overview NEPTAZANE is listed in Drugs@FDA under application 011721 (NDA). Marketing status: Discontinued Active ingredient METHAZOLAMIDE Form and strength TABLET;ORAL - 50MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor LEDERLE Submission history Latest submission status date: 2009-03-13 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.